Previous studies have demonstrated that ARNT expression is significantly upregulated in a variety of malignant tumors, including renal cell carcinoma [10], lymphoid cancer [11], multiple myeloma [12], breast cancer [13], and medulloblastoma [14]. Here, ARNT is linked to cancer.